These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 22245967)

  • 1. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation.
    Anczuków O; Rosenberg AZ; Akerman M; Das S; Zhan L; Karni R; Muthuswamy SK; Krainer AR
    Nat Struct Mol Biol; 2012 Jan; 19(2):220-8. PubMed ID: 22245967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation.
    Shimoni-Sebag A; Lebenthal-Loinger I; Zender L; Karni R
    Carcinogenesis; 2013 Nov; 34(11):2498-504. PubMed ID: 23843040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
    Das S; Anczuków O; Akerman M; Krainer AR
    Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRSF1-Regulated Alternative Splicing in Breast Cancer.
    Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
    Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
    Karni R; de Stanchina E; Lowe SW; Sinha R; Mu D; Krainer AR
    Nat Struct Mol Biol; 2007 Mar; 14(3):185-93. PubMed ID: 17310252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells.
    Gautrey HL; Tyson-Capper AJ
    PLoS One; 2012; 7(12):e51497. PubMed ID: 23284704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia.
    Zou L; Zhang H; Du C; Liu X; Zhu S; Zhang W; Li Z; Gao C; Zhao X; Mei M; Bao S; Zheng H
    J Hematol Oncol; 2012 Jul; 5():42. PubMed ID: 22839530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD.
    Leu S; Lin YM; Wu CH; Ouyang P
    J Cell Sci; 2012 Jul; 125(Pt 13):3164-72. PubMed ID: 22454513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
    Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
    Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.
    Verduci L; Simili M; Rizzo M; Mercatanti A; Evangelista M; Mariani L; Rainaldi G; Pitto L
    J Biol Chem; 2010 Dec; 285(50):39551-63. PubMed ID: 20923760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1.
    Lee M; Dworkin AM; Gildea D; Trivedi NS; ; Moorhead GB; Crawford NP
    Oncogene; 2014 Apr; 33(14):1818-27. PubMed ID: 23604122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.
    Das S; Krainer AR
    Mol Cancer Res; 2014 Sep; 12(9):1195-204. PubMed ID: 24807918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
    Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
    J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1.
    Kanehiro Y; Todo K; Negishi M; Fukuoka J; Gan W; Hikasa T; Kaga Y; Takemoto M; Magari M; Li X; Manley JL; Ohmori H; Kanayama N
    Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1216-21. PubMed ID: 22232677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
    Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE
    Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 Replication.
    Paz S; Lu ML; Takata H; Trautmann L; Caputi M
    J Virol; 2015 Jun; 89(12):6275-86. PubMed ID: 25855733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.
    Comiskey DF; Jacob AG; Singh RK; Tapia-Santos AS; Chandler DS
    Nucleic Acids Res; 2015 Apr; 43(8):4202-18. PubMed ID: 25845590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1.
    Wang X; Juan L; Lv J; Wang K; Sanford JR; Liu Y
    BMC Genomics; 2011 Dec; 12 Suppl 5(Suppl 5):S8. PubMed ID: 22369183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
    Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
    J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.